| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.993 | 0.001 | 0.993 | T cell inhibitor | 0.939 0.001 DBMET01913 | ||
| 0.958 | 0.004 | 0.958 | Apoptosis agonist | 0.919 0.005 DBMET01913 | ||
| 0.919 | 0.001 | 0.919 | Falcipain inhibitor | 0.841 0.001 DBMET01913 | ||
| 0.918 | 0.001 | 0.918 | Falcipain 2 inhibitor | 0.839 0.001 DBMET01913 | ||
| 0.92 | 0.004 | 0.92 | Angiogenesis inhibitor | 0.757 0.006 DBMET01913 | ||
| 0.861 | 0.003 | 0.887 | Angiogenesis stimulant | 0.887 0.002 DBMET01913 | DBMET01913 | |
| 0.795 | 0.004 | 0.795 | DNA damaging | 0.733 0.004 DBMET01913 | ||
| 0.78 | 0.004 | 0.78 | Immunosuppressant | 0.777 0.004 DBMET01913 | ||
| 0.687 | 0.005 | 0.687 | Hypolipemic | 0.607 0.006 DBMET01913 | ||
| 0.68 | 0.003 | 0.68 | Interleukin 6 antagonist | 0.643 0.003 DBMET01913 | ||
| 0.657 | 0.012 | 0.794 | Antibacterial | 0.794 0.004 DBMET01913 | DBMET01913 | |
| 0.63 | 0.006 | 0.747 | DNA synthesis inhibitor | 0.747 0.004 DBMET01913 | DBMET01913 | |
| 0.621 | 0.002 | 0.734 | Interferon gamma antagonist | 0.734 0.001 DBMET01913 | DBMET01913 | |
| 0.561 | 0.042 | 0.561 | Caspase 9 stimulant | 0.492 0.063 DBMET01913 | ||
| 0.482 | 0.004 | 0.482 | Antibacterial (Helicobacter pylori) | 0.307 0.006 DBMET01913 | ||
| 0.451 | 0.003 | 0.451 | Interleukin 12 antagonist | 0.448 0.003 DBMET01913 | ||
| 0.477 | 0.048 | 0.77 | Transcription factor NF kappa B inhibitor | 0.77 0.015 DBMET01913 | DBMET01913 | |
| 0.448 | 0.02 | 0.537 | Nitric oxide antagonist | 0.537 0.013 DBMET01913 | DBMET01913 | |
| 0.371 | 0.047 | 0.557 | Apoptosis antagonist | 0.557 0.014 DBMET01913 | DBMET01913 | |
| 0.328 | 0.044 | 0.57 | Hypoglycemic | 0.57 0.01 DBMET01913 | DBMET01913 | |
| 0.256 | 0.072 | 0.329 | Tumour necrosis factor alpha release inhibitor | 0.329 0.044 DBMET01913 | DBMET01913 | |
| 0.172 | 0.008 | 0.172 | Glutathione S-transferase inhibitor | 0.1 0.038 DBMET01913 | ||
| 0.161 | 0.022 | 0.161 | Ca2+-transporting ATPase inhibitor | 0.145 0.058 DBMET01913 | ||
| 0.183 | 0.05 | 0.183 | Arachidonic acid antagonist | |||
| 0.198 | 0.079 | 0.198 | Neurotrophic factor enhancer | 0.151 0.136 DBMET01913 | ||
| 0.287 | 0.174 | 0.712 | Cyclophilin D inhibitor | 0.712 0.013 DBMET01913 | DBMET01913 | |
| 0.236 | 0.126 | 0.259 | Caspase 3 stimulant | 0.259 0.104 DBMET01913 | DBMET01913 | |
| 0.147 | 0.043 | 0.147 | Interleukin 1b antagonist | 0.102 0.079 DBMET01913 | ||
| 0.105 | 0.015 | 0.105 | Bcl2 antagonist | 0.063 0.051 DBMET01913 | ||
| 0.158 | 0.071 | 0.229 | Diuretic | 0.229 0.035 DBMET01913 | DBMET01913 | |
| 0.107 | 0.026 | 0.115 | Na+ K+ transporting ATPase inhibitor | 0.115 0.019 DBMET01913 | DBMET01913 | |
| 0.11 | 0.031 | 0.118 | Transcription factor NF kappa B stimulant | 0.118 0.026 DBMET01913 | DBMET01913 | |
| 0.219 | 0.149 | 0.352 | Cholesterol antagonist | 0.352 0.063 DBMET01913 | DBMET01913 | |
| 0.092 | 0.04 | 0.093 | Glycine receptor antagonist | 0.093 0.039 DBMET01913 | DBMET01913 | |
| 0.098 | 0.047 | 0.198 | Antineoplastic antibiotic | 0.198 0.021 DBMET01913 | DBMET01913 | |
| 0.071 | 0.02 | 0.076 | Lipocortins synthesis agonist | 0.076 0.016 DBMET01913 | DBMET01913 | |
| 0.153 | 0.106 | 0.398 | Hepatoprotectant | 0.398 0.013 DBMET01913 | DBMET01913 | |
| 0.104 | 0.057 | 0.104 | Anabolic | |||
| 0.078 | 0.041 | 0.078 | Glycine receptor agonist | 0.071 0.054 DBMET01913 | ||
| 0.063 | 0.029 | 0.122 | Protein 50S ribosomal subunit inhibitor | 0.122 0.009 DBMET01913 | DBMET01913 | |
| 0.168 | 0.156 | 0.168 | RNA-directed DNA polymerase inhibitor | |||
| 0.032 | 0.032 | 0.069 | Antibiotic Aminoglycoside-like | 0.069 0.006 DBMET01913 | DBMET01913 | |
| 0.018 | 0.02 | 0.022 | Corticosteroid-like | 0.022 0.014 DBMET01913 | DBMET01913 | |
| 0.133 | 0.135 | 0.147 | Lipocortins synthesis antagonist | 0.147 0.109 DBMET01913 | DBMET01913 | |
| 0.042 | 0.046 | 0.047 | Glucose-6-phosphate isomerase inhibitor | 0.047 0.034 DBMET01913 | DBMET01913 | |
| 0.009 | 0.014 | 0.013 | Antibiotic Macrolide-like | 0.013 0.011 DBMET01913 | DBMET01913 | |
| 0.023 | 0.03 | 0.035 | Toll-Like receptor 4 agonist | 0.035 0.007 DBMET01913 | DBMET01913 | |
| 0.192 | 0.204 | 0.37 | Interleukin 2 agonist | 0.37 0.037 DBMET01913 | DBMET01913 | |
| 0.077 | 0.093 | 0.228 | Topoisomerase I inhibitor | 0.228 0.02 DBMET01913 | DBMET01913 | |
| 0.012 | 0.031 | 0.016 | Telomerase stimulant | 0.016 0.014 DBMET01913 | DBMET01913 | |
| 0.092 | 0.113 | 0.111 | Alpha-N-acetylglucosaminidase inhibitor | 0.111 0.087 DBMET01913 | DBMET01913 | |
| 0.015 | 0.042 | 0.053 | Protein 30S ribosomal subunit inhibitor | 0.053 0.008 DBMET01913 | DBMET01913 | |
| 0.018 | 0.049 | 0.024 | Vanilloid 2 agonist | 0.024 0.02 DBMET01913 | DBMET01913 | |
| 0.035 | 0.087 | 0.049 | Alpha-mannosidase inhibitor | 0.049 0.045 DBMET01913 | DBMET01913 | |
| 0.032 | 0.112 | 0.078 | Phosphofructokinase-1 inhibitor | 0.078 0.042 DBMET01913 | DBMET01913 | |
| 0.1 | 0.187 | 0.14 | Melanin inhibitor | 0.14 0.097 DBMET01913 | DBMET01913 | |
| 0.024 | 0.125 | 0.041 | Microtubule stabilization | 0.041 0.04 DBMET01913 | DBMET01913 | |
| 0.065 | 0.17 | 0.161 | Toll-Like receptor 4 antagonist | 0.161 0.016 DBMET01913 | DBMET01913 | |
| 0.055 | 0.159 | 0.087 | UDP-glucose 4-epimerase inhibitor | 0.087 0.079 DBMET01913 | DBMET01913 | |
| 0.066 | 0.171 | 0.105 | Microtubule formation inhibitor | 0.105 0.083 DBMET01913 | DBMET01913 | |
| 0.045 | 0.196 | 0.092 | ATPase (Vacuolar H+) inhibitor | 0.092 0.053 DBMET01913 | DBMET01913 | |
| 0.124 | 0.285 | 0.339 | Peptidyltransferase inhibitor | 0.339 0.014 DBMET01913 | DBMET01913 | |
| 0.036 | 0.229 | 0.097 | Expectorant | 0.097 0.071 DBMET01913 | DBMET01913 | |
| 0.043 | 0.259 | 0.112 | Amylase inhibitor | 0.112 0.086 DBMET01913 | DBMET01913 | |
| 0.016 | 0.235 | 0.258 | Selectin antagonist | 0.258 0.008 DBMET01913 | DBMET01913 | |
| 0.049 | 0.295 | 0.104 | Cyclooxygenase 3 inhibitor | 0.104 0.097 DBMET01913 | DBMET01913 | |
| 0.074 | 0.324 | 0.418 | Antioxidant | 0.418 0.032 DBMET01913 | DBMET01913 | |
| 0.052 | 0.345 | 0.281 | Immunostimulant | 0.281 0.085 DBMET01913 | DBMET01913 | |
| 0.079 | 0.405 | 0.446 | Antithrombotic | 0.446 0.039 DBMET01913 | DBMET01913 | |
| 0.049 | 0.408 | 0.163 | Vasodilator | 0.163 0.139 DBMET01913 | DBMET01913 | |
| 0.021 | 0.56 | 0.327 | Free radical scavenger | 0.327 0.045 DBMET01913 | DBMET01913 | |
| 0.013 | 0.608 | 0.119 | Lipid peroxidase inhibitor | 0.119 0.095 DBMET01913 | DBMET01913 | |
| 0.009 | 0.902 | 0.143 | Platelet adhesion inhibitor | 0.143 0.114 DBMET01913 | DBMET01913 | |
| 0.007 | 0.924 | 0.345 | Antiinflammatory | 0.345 0.176 DBMET01913 | DBMET01913 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |